← All trials
NCT05979051
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 16, 2023
- Primary completion
- Mar 21, 2026
- Completion date
- May 16, 2027
- First posted
- Aug 7, 2023
- Last posted
- Dec 11, 2023
- Enrollment
- 112
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hengrui Therapeutics, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.